Legal Opinion
Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.
Court of Appeals for the Federal Circuit
Decided April 3, 2009No. 2008-1248PublishedCited by 15 opinions
1Opinion of the Court
MOORE, Circuit Judge.
Plaintiffs-Appellees Ariad Pharmaceuticals, Inc., Massachusetts Institute of Technology, the Whitehead Institute for Biomedical Research, and the Presidents and Fellows of Harvard College (collectively, Ariad) sued Defendant-Appellant Eli Lilly and Company (Lilly) in the United States District Court for the District of Massachusetts for infringement of claims 80, 95,144, and 145 (the asserted claims) of U.S. Patent No. 6,410,516 (the '516 patent). A jury found infringement of claims 80 and 95 with respect to Lilly’s drug Evista, and claims 144 and 145 with respect to…
2Cases cited27 opinions
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Vas-Cath Incorporated and Gambro, Inc. v. Sakharam D. Mahurkar, and Quinton Instruments CompanyCourt of Appeals for the Federal Circuit · 1991
- O'Reilly v. MorseSupreme Court of the United States · 1854
- Wms Gaming Inc. v. International Game TechnologyCourt of Appeals for the Federal Circuit · 1999
- Star Scientific, Inc. v. R.J. Reynolds Tobacco Co.Court of Appeals for the Federal Circuit · 2008
22 more not listed; retrieve them via the Exa API.
3Cited by15 opinions
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2010
- Optium Corp. v. Emcore Corp.Court of Appeals for the Federal Circuit · 2010
- Purdue Pharma Products L.P. v. Par Pharmaceutical, Inc.District Court, D. Delaware · 2009
- Cordance Corp. v. Amazon. Com, Inc.District Court, D. Delaware · 2009
- Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.Court of Appeals for the Federal Circuit · 2009
10 more not listed; retrieve them via the Exa API.